People: Synergetics USA Inc (SURG.O)

SURG.O on Consolidated Issue listed on NASDAQ Capital Market

19 Dec 2014
Price Change (% chg)

$0.22 (+5.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Hable, David 

Brief Biography

Mr. David M. Hable is President, Chief Executive Officer, Director of Synergetics USA, Inc. Prior to joining the Company, Mr. Hable served as President and Chief Executive Officer of Afferent Corporation, a venture capital backed medical device company focused on neuro stimulation therapies. Previously, he was Chairman of the Board of ONI Medical Systems, Inc., a developer and marketer of magnetic resonance imaging equipment for extremity applications in non-hospital settings. Mr. Hable also spent over 20 years with Johnson & Johnson working in business units that developed and marketed a wide range of diagnostic and therapeutic products for the treatment of central nervous system disorders. From 1998 to 2003, Mr. Hable served as Codman’s worldwide President, leading all functions in the company, both domestically and internationally. Mr. Hable has overall responsibility for the management of the Company.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
410,800 -- 103,703 611,263

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Hable


Pamela Boone


Michael Fanning


Jason Stroisch


Robert Blankemeyer


Lawrence Cardinale

As Of 30 Jul 2013
Search Stocks